IRVINE, CA, August 9, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced that it has received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) stating that the Company has regained compliance with the Nasdaq minimum bid price continued listing requirement and the matter is now closed. The … Continue reading “ONCOCYTE REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS”
Breaking News
Breaking News
PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study
PaxMedica to discuss significance of Phase 3 study results Interview to be webcast on Tuesday,…
August 8, 2023
Breaking News
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023 IRVINE,…
August 8, 2023
Breaking News
Titan NRG, Inc. (TTNN) Acquires New Equipment
TUCSON, AZ, August 7, 2023 – Titan NRG, Inc. (OTC PINK:TTNN) (“Titan NRG”) a leader…
August 7, 2023